**Question:** Burkitt's lymphoma is -

a) B cell lymphoma
b) 6, 14 translocation
c) Can present as abdominal mass
d) Radiotherapy is used in treatment

**Correct Answer:**

**Core Concept:** Burkitt's lymphoma is a type of non-Hodgkin's lymphoma characterized by extremely rapid growth and poor prognosis. It is named after the British pathologist Dennis Burkitt who first described it in 1958. The disease is typically caused by the EBV (Epstein-Barr virus) and is associated with a specific genetic abnormality - the t(8;14)(q24;q32) translocation.

**Why the Correct Answer is Right:** Burkitt's lymphoma is classified as a B cell lymphoma, specifically involving the activation of the MYC oncogene due to the t(8;14)(q24;q32) translocation. This translocation results in the overexpression of the MYC gene, leading to uncontrolled cell proliferation and the characteristic rapid growth seen in Burkitt's lymphoma.

**Why Each Wrong Option is Incorrect:**

a) Option A: B cell lymphoma is a correct classification for Burkitt's lymphoma, but it doesn't specifically address the genetic abnormality or the cause of the disease.

b) Option B: The t(8;14)(q24;q32) translocation is the primary genetic abnormality in Burkitt's lymphoma, and addressing this translocation provides a more accurate and relevant explanation.

c) Option C: While abdominal mass can be a presentation of Burkitt's lymphoma, the question asks for the core concept of the disease, which is the genetic abnormality and the cause of the disease.

d) Option D: Radiotherapy is used in the treatment of Burkitt's lymphoma, but the question focuses on the core concept of the disease, not its management.

**Clinical Pearl:** Burkitt's lymphoma is a clinical pearl for medical students, residents, and practicing physicians to understand the key genetic abnormality and pathogenesis of the disease, which is crucial for accurate diagnosis and appropriate treatment planning. This knowledge helps to differentiate Burkitt's lymphoma from other lymphomas and ensures that oncologists choose the most effective treatment strategy, including appropriate chemotherapy regimens and targeted therapies when available.